Raymond H Chan
Overview
Explore the profile of Raymond H Chan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
65
Citations
1369
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chan R, van der Wal L, Liberato G, Rowin E, Soslow J, Maskatia S, et al.
JAMA Cardiol
. 2024 Sep;
9(11):1001-1008.
PMID: 39320884
Importance: The ability to predict sudden cardiac death (SCD) in children and adolescents with hypertrophic cardiomyopathy (HCM) is currently inadequate. Late gadolinium enhancement (LGE) by cardiovascular magnetic resonance (CMR) imaging...
2.
Scolari F, Brahmbhatt D, Abelson S, Lee D, Kim R, Pedarzadeh A, et al.
Eur J Heart Fail
. 2024 Aug;
26(10):2193-2202.
PMID: 39091134
Aims: The heterogeneous phenotype of hypertrophic cardiomyopathy (HCM) is still not fully understood. Clonal haematopoiesis (CH) is emerging as a cardiovascular risk factor potentially associated with adverse clinical events. The...
3.
Bonaventura J, Rowin E, Chan R, Chin M, Puchnerova V, Polakova E, et al.
J Am Heart Assoc
. 2024 May;
13(10):e033565.
PMID: 38757491
Background: The genetic basis of hypertrophic cardiomyopathy (HCM) is complex, and the relationship between genotype status and clinical outcome is incompletely resolved. Methods And Results: We assessed a large international...
4.
Habib M, Hoss S, Adler A, Katz O, Halloun Habib H, Fardfini K, et al.
Circ Cardiovasc Imaging
. 2023 Oct;
16(11):e015555.
PMID: 37905406
No abstract available.
5.
Li J, Jia H, Zhou J, Huang X, Xu L, Jia S, et al.
Nat Commun
. 2023 Aug;
14(1):5009.
PMID: 37591881
Continuous monitoring of arterial blood pressure (BP) outside of a clinical setting is crucial for preventing and diagnosing hypertension related diseases. However, current continuous BP monitoring instruments suffer from either...
6.
Bhandari V, Kim R, Faghfoury H, Silver J, Chan R, Ding Q, et al.
Can J Neurol Sci
. 2023 Aug;
51(4):585-587.
PMID: 37577974
No abstract available.
7.
Fahmy A, Rowin E, Jaafar N, Chan R, Rodriguez J, Nakamori S, et al.
JACC Cardiovasc Imaging
. 2023 Jun;
17(1):16-27.
PMID: 37354155
Background: Late gadolinium enhancement (LGE) scar burden by cardiac magnetic resonance is a major risk factor for sudden cardiac death (SCD) in hypertrophic cardiomyopathy (HCM). However, there is currently limited...
8.
Navidi Z, Sun J, Chan R, Hanneman K, Al-Arnawoot A, Munim A, et al.
PLOS Digit Health
. 2023 Feb;
2(1):e0000159.
PMID: 36812626
Scar quantification on cardiovascular magnetic resonance (CMR) late gadolinium enhancement (LGE) images is important in risk stratifying patients with hypertrophic cardiomyopathy (HCM) due to the importance of scar burden in...
9.
Lee D, Montazeri M, Bataiosu R, Hoss S, Adler A, Nguyen E, et al.
JACC Cardiovasc Imaging
. 2022 Oct;
15(10):1696-1711.
PMID: 36202449
Background: Left ventricular (LV) apical aneurysms in hypertrophic cardiomyopathy (HCM) are a recognized risk marker for adverse cardiovascular events. There is variable practice among clinicians and discordance between international guidelines...
10.
Habib M, Adler A, Hoss S, Hanneman K, Katz O, Halloun Habib H, et al.
Am J Cardiol
. 2022 Jun;
176:125-131.
PMID: 35644698
In this study, we aimed to assess a large cohort of nonapical hypertrophic cardiomyopathy (HC) patients who have undergone 2 serial cardiac magnetic resonance studies to examine morphological dynamics and...